United States · FDA National Drug Code directory
Ambrisentan
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70710-1180_2b40da77-ad23-44bc-8556-1039a299da4c
- Product NDC
- 70710-1180
- Form
- TABLET, FILM COATED
- Composition / generic term
- Ambrisentan
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190412
- Source listing expiry
- 20271231
Source-listed ingredients
- AMBRISENTAN — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE (70710-1180-1) · 70710-1180-1
- 30 TABLET, FILM COATED in 1 BOTTLE (70710-1180-3) · 70710-1180-3
- 1 BLISTER PACK in 1 CARTON (70710-1180-7) / 10 TABLET, FILM COATED in 1 BLISTER PACK · 70710-1180-7
- 3 BLISTER PACK in 1 CARTON (70710-1180-8) / 10 TABLET, FILM COATED in 1 BLISTER PACK · 70710-1180-8
- 90 TABLET, FILM COATED in 1 BOTTLE (70710-1180-9) · 70710-1180-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →